Search for European Projects

23 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Multi-country cOllaborative project on the rOle of Diet, FOod-related behaviour, and Obesity in the prevention of Depression (MooDFOOD) (MOODFOOD)

Start date: Jan 1, 2014, End date: Dec 31, 2018,

MooDFOOD is a Multi-country cOllaborative project on the rOle of Diet, Food-related behaviour, and Obesity in the prevention of Depression. Depression is one of the most prevalent, severe and disabling disorders in the EU and places a heavy burden on individuals and families. A large proportion of the EU population is overweight which increases depression risk. Improving food-related behaviour and ...
Read Project

 17

 FINISHED 

Aggression subtyping for improved insight and treatment innovation in psychiatric disorders (AGGRESSOTYPE)

Start date: Nov 1, 2013, End date: Oct 31, 2018,

Aggression is a basic physiological trait with important roles throughout evolution, both in defence and predation. When expressed in humans in the wrong context, aggression leads to maladjustment, social impairment and crime. Despite this, knowledge about aggression aetiology is limited and current treatment strategies are insufficient. Contingent to a subdivision into impulsive and instrumental ...
Read Project

 27

 FINISHED 

Consistently Optimised Resilient Secure Global Supply-Chains (CORE)

Start date: May 1, 2014, End date: Apr 30, 2018,

CORE will consolidate, amplify, extend and demonstrate EU knowledge and capabilities and international co-operation for securing supply chains whilst maintaining or improving business performance, with specific reference to key Supply Chain Corridors.CORE will be driven by the requirements of:• the Customs, law enforcement authorities, and other agencies nationally and internationally to increase ...
Read Project

 72

 FINISHED 

European Medical Information Framework (EMIF)

Start date: Jan 1, 2013, End date: Dec 31, 2017,

In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected, either in routine Electronic Healthcare Record (EHR) databases, through research-driven cohort studies, in biobanks or related efforts. However, data sources are typically fragmented and contain information gaps which prevent their full exploitation. EMIF aim ...
Read Project

 64

 FINISHED 

European Lead Factory (EUC²LID)

Start date: Jan 1, 2013, End date: Dec 31, 2017,

The European Lead Factory concept proposed by the EUC2LID Consortium relates to the discovery of novel small molecule candidates to serve as starting points for subsequent optimization to either drug candidates or high-quality pharmacological tools for the experimental validation of targets. The concept intends to bridge academic and applied research interests. The European Lead Factory will provi ...
Read Project

 34

 FINISHED 

Efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial (WAKE-UP)

Start date: Dec 1, 2011, End date: Nov 30, 2017,

WAKE-UP is an investigator-initiated, multicentre, randomised, double-blind, placebo-controlled trial designed to test efficacy and safety of MRI-based intravenous thrombolysis in patients with wake-up stroke. Every year 1.5 million patients suffer a stroke in the EU. Up to 20% of stroke patients wake up with stroke symptoms. Currently these patients are excluded from thrombolysis which is the onl ...
Read Project

 13

 FINISHED 

Emerging mental health systems in low- and middle-income countries (EMERALD)

Start date: Nov 1, 2012, End date: Oct 31, 2017,

The objective of the EMERALD Project is to improve mental health outcomes by enhancing health system performance.The key issues addressed are: (i) adequate, fair & sustainable resourcing: using human, infrastructural, informational & financial resource inputs to effectively deliver better mental health services; (ii) integrated service provision: enhancing access to integrated community care; and ...
Read Project

 12

 FINISHED 

Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope (EU-CERT-ICD)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

An estimated 500.000 sudden cardiac deaths (SCD) occur each year in the European Union. Patients at risk for SCD may benefit from prophylactic treatment with an implantable cardioverter-defibrillator (ICD). ICD implantations have dramatically increased in recent years leading to multi-billion Euros of costs with significant regional disparities across Europe. Information on risks, benefits and cos ...
Read Project

 27

 FINISHED 

a Multimodal Authoring and Gaming Environment for Location-based coLlaborative AdveNtures (MAGELLAN)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

Computer games represent a vast economic market, a key driver of technology, and an increasingly powerful medium for a broad range of applications. The latest wave of innovation for computer games is 'mobile' and, more precisely, 'location-based'. These outdoors mobile experiences are radically different from traditional computer games or their mobile equivalent. They focus the players' attention ...
Read Project

 13

 FINISHED 

Translational Adolescent and Childhood Therapeutic Interventions in Compulsive Syndromes (TACTICS)

Start date: Jan 1, 2012, End date: Jun 30, 2017,

Compulsivity is characterized by a repetitive, irresistible urge to perform a behavior, the experience of loss of voluntary control over this intense urge, the diminished ability to delay or inhibit thoughts or behaviors, and the tendency to perform repetitive acts in a habitual or stereotyped manner. Compulsivity is a cross-disorder trait underlying phenotypically distinct psychiatric disorders t ...
Read Project

 13

 FINISHED 

European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS)

Start date: Apr 1, 2012, End date: Mar 31, 2017,

Despite dramatic advances in molecular and imaging technologies, there are currently no effective pharmacological treatments for the core symptoms of autism spectrum disorder (ASD). Major obstructions to this include a lack of aetiologically-driven or pathophysiologically-accurate animal models; an absence of tests that indicate efficacy; and reliance of clinical trials on DSM/ICD10 categories wh ...
Read Project

 29

 FINISHED 

European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke (EuroHYP-1)

Start date: Feb 1, 2012, End date: Jan 31, 2017,

The consortium led by UKER and EuroHYP, the European Stroke Research Network for Hypothermia, proposes a large, multicentre clinical trial which will assess mild hypothermia as a novel treatment for ischemic stroke.Stroke is the second cause of death world-wide and the second cause of lost disability-adjusted life years in high-income countries. Stroke incidence rises exponentially with age, so it ...
Read Project

 38

 FINISHED 

EUROPEAN FORENSIC GENETICS Network of Excellence (EUROFORGEN-NOE)

Start date: Jan 1, 2012, End date: Dec 31, 2016,

The EUROFORGEN-NoE proposal aims to develop a network of excellence for the creation of a European Virtual Centre of Forensic Genetic Research. Forensic genetics is a highly innovative field of applied science with a strong impact on the security of citizens. However, the genetic methods to identify offenders as well as the creation of national DNA databases have caused concerns to the possible vi ...
Read Project

 19

 FINISHED 

A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease (NILVAD)

Start date: Jan 1, 2012, End date: Dec 31, 2016,

Alzheimer’s disease (AD) is an ever-increasing public health concern among the aging population and is the most common form of dementia affecting more than 15 million individuals worldwide and around 5 million Europeans. The direct and indirect costs of AD and other dementias amount to more than €440,000 million each year (www.alz.org, 2010).Even modest therapeutic advances that delay disease onse ...
Read Project

 17

 FINISHED 

Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE)

Start date: Nov 1, 2010, End date: Apr 30, 2016,

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children, affecting approximately 5% children in Europe. Methylphenidate (MPH) is the most-commonly prescribed medication for ADHD children; it is also increasingly used in ADHD adults. In 2007, the European Commission requested a referral to the Committee for Medicinal Products for Human Use ...
Read Project

 17

 FINISHED 

Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia (CRESTAR)

Start date: Nov 1, 2011, End date: Oct 31, 2015,

Treatment resistant schizophrenia (TRS) is the most disabling of all psychiatric illnesses, affecting about 1/3 of patients (~1 million Europeans), a considerable economic and social burden. First-line treatments include atypical (e.g. olanzapine) and typical (e.g. haloperidol) antipsychotics. The original atypical, clozapine, is a final option, and although it is the only antipsychotic shown to b ...
Read Project

 11

 FINISHED 

Linked Knowledge in Manufacturing, Engineering and Design for Next-Generation Production (LinkedDesign)

Start date: Sep 1, 2011, End date: Aug 31, 2015,

What is clearly missing in the current ICT landscape for manufacturing is an integrated, holistic view on data across the full product lifecycle. Especially the design and engineering of products and manufacturing processes is decoupled from the actual process execution. As experiences of the past show, a tight integration of all tools used throughout a product lifetime is not feasible.LinkkME add ...
Read Project

 14

 FINISHED 

European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI)

Start date: May 1, 2010, End date: Apr 30, 2015,

The aim of EU-GEI is to identify the interactive genetic, clinical and environmental determinants involved in the development, severity and outcome of schizophrenia (EU-GEI, Schiz. Res. 2008; 102: 21-6). In order to identify these interactive determinants, EU-GEI will employ family-based, multidisciplinary research paradigms, which allow for the efficient assessment of gene-environment interaction ...
Read Project

 27

 FINISHED 

Novel Methods leading to New Medications in Depression and Schizophrenia (NEWMEDS)

Start date: Sep 1, 2009, End date: Feb 28, 2015,

Despite dramatic advances in molecular and imaging technologies and nearly 1 5,000 articles on schizophrenia and depression (S&D) there are few novel treatments. We think this is because of three major “bottle-necks”: a lack of etiologically-driven or pathophysiologically-accurate animal models; a lack of tests that provide indication of efficacy in healthy volunteers; and the reliance of clinical ...
Read Project

 20

 FINISHED 

A Treatment-Oriented Research Project of NCL Disorders as a Major Cause of Dementia in Childhood (DEM-CHILD)

Start date: Oct 1, 2011, End date: Sep 30, 2014,

"The DEM-CHILD project focusses on the main cause for childhood dementia in Europe, the neuronal ceroid lipofuscinoses (NCLs). The NCLs are neurodegenerative diseases characterized by dementia, blindness, epilepsy and physical decline leading to an early death of the patients. Since no cure is currently available, these disorders represent a serious social, medical, and economic challenge.To date, ...
Read Project

 13

 FINISHED 

Monitoring Atmospheric Composition and Climate Interim Implementation (MACC II)

Start date: Nov 1, 2011, End date: Jul 31, 2014,

MACC II (Monitoring Atmospheric Composition and Climate – Interim Implementation) is designed to meet the requirements that have been expressed for prototype operational GMES services for the atmospheric domain. From late-2011 MACC II will continue the operation and development of the GMES service lines established by the MACC project and prepare for its transition in 2014 to become the atmospheri ...
Read Project

 39

 FINISHED 

Use of innovative strategies for beta-cell imaging in diabetes mellitus (BetaImage)

Start date: Oct 1, 2008, End date: Mar 31, 2013,

The development of sensitive, non-invasive methods for the characterisation and quantification of beta-cell mass would greatly enhance our means for gaining understanding of the pathophysiology of diabetes and allow the development of novel therapies to prevent, halt and reverse the disease. The aim of this project is to develop and apply innovative approaches for beta-cell imaging, the emphasis b ...
Read Project

 10

 FINISHED 

Open Public Extended Network metering (OPEN meter)

Start date: Jan 1, 2009, End date: Jun 30, 2011,

New smart multi-metering or multi-functional Advanced Metering Infrastructure (AMI) is capable of creating value for energy consumers, network operators, metering operators and retailers. AMI will provide better services for customers in various ways: not only by more accurate metering and billing, but also by easing the supplier switching process and also by facilitating demand response to price ...
Read Project

 20